...they pull some overly bullish articles on AMPE off their site, yet they allow this garbage to be posted? Pathetic. Just who exactly are they working for? The bottom line is that Ampion, Optina and Luoxis will all be clinically validated for better or worse by the end of the year. So why write such a BS article?